Advancing placenta accreta spectrum diagnosis: is 3-T MRI or combined MRI with ultrasound the answer?

OBJECTIVE: This study compares the diagnostic performance of US and 3-T MRIin diagnosing placenta accreta spectrum (PAS) disorder using final histopathological and surgical findings and explores the benefit of using a combined MRI and US approach to diagnose PAS. MATERIALS AND METHODS: We retrospectively reviewed electronic medical records of all patients undergoing 3-T MRIplacenta at our institution between January 2020 and November 2023. The gold standard for PAS outcome was histopathology, and where unavailable, we referred to the operative notes. Patients without surgical or histopathologic data, and non-diagnostic MRI studies were excluded. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), confidence intervals, and p-values were generated for MRI, US, and combined MRI + US to detect PAS with subgroup analysis for placenta accreta/increta and percreta. RESULTS: Eighty-eight patients met the inclusion criteria. The sensitivity and specificity of MRI for all PAS was 100.0% and 80.0% (p < 0.001), compared to US 89.5% and 62.0% (p < 0.001), and combined MRI + US 100.0% and 56.0% (p < 0.001), respectively. For diagnosing placenta percreta, MRI had a sensitivity and specificity of 83.3% and 94.3% (p < 0.001), compared to US 55.6% and 94.3% (p < 0.001) and combined MRI + US 83.3% and 92.9% (p < 0.001). CONCLUSION: Both US and 3-T MRIdemonstrated strong diagnostic performances for detecting PAS, with 3-T MRIdemonstrating stronger performance in this selective cohort, and not further improved by including US data. The continued use of US, MRI and clinical data for evaluating PAS disorder treatment options is recommended. KEY POINTS: Question No dedicated study has evaluated the diagnostic performance of 3-T MRIor the combined use of MRI with US in PAS. Findings 3-T MRIdemonstrates high sensitivity and specificity for diagnosing PAS. The combined MRI and US assessment does not further improve diagnostic performance for PAS. Critical relevance statement 3-T MRImay be particularly useful as an adjunct in selected high-risk patients, equivocal ultrasound cases, or cases requiring assessment of myoinvasive disease and multidisciplinary surgical planning.

Authors

Institutions

Publication Details

Journal
Insights into Imaging
Published
2026-11-18
DOI
https://doi.org/10.1186/s13244-026-02448-5
Primary Topic
Maternal and fetal healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Advancing placenta accreta spectrum diagnosis: is 3-T MRI or combined MRI with ultrasound the answer?

Debbie Nisbet, Clair L. Shadbolt, Ekaterina Alibrahim, Sheng Fei Oon et al.
2 links
Insights into Imaging
Maternal and fetal healthcare
article

Advancing placenta accreta spectrum diagnosis: is 3-T MRI or combined MRI with ultrasound the answer?

Debbie Nisbet, Clair L. Shadbolt, Ekaterina Alibrahim, Sheng Fei Oon, Jacqui Keene, Danielle Richmond, Michael Mil, Poonam Charan, Samantha Tan
article en

Abstract

OBJECTIVE: This study compares the diagnostic performance of US and 3-T MRIin diagnosing placenta accreta spectrum (PAS) disorder using final histopathological and surgical findings and explores the benefit of using a combined MRI and US approach to diagnose PAS. MATERIALS AND METHODS: We retrospectively reviewed electronic medical records of all patients undergoing 3-T MRIplacenta at our institution between January 2020 and November 2023. The gold standard for PAS outcome was histopathology, and where unavailable, we referred to the operative notes. Patients without surgical or histopathologic data, and non-diagnostic MRI studies were excluded. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), confidence intervals, and p-values were generated for MRI, US, and combined MRI + US to detect PAS with subgroup analysis for placenta accreta/increta and percreta. RESULTS: Eighty-eight patients met the inclusion criteria. The sensitivity and specificity of MRI for all PAS was 100.0% and 80.0% (p < 0.001), compared to US 89.5% and 62.0% (p < 0.001), and combined MRI + US 100.0% and 56.0% (p < 0.001), respectively. For diagnosing placenta percreta, MRI had a sensitivity and specificity of 83.3% and 94.3% (p < 0.001), compared to US 55.6% and 94.3% (p < 0.001) and combined MRI + US 83.3% and 92.9% (p < 0.001). CONCLUSION: Both US and 3-T MRIdemonstrated strong diagnostic performances for detecting PAS, with 3-T MRIdemonstrating stronger performance in this selective cohort, and not further improved by including US data. The continued use of US, MRI and clinical data for evaluating PAS disorder treatment options is recommended. KEY POINTS: Question No dedicated study has evaluated the diagnostic performance of 3-T MRIor the combined use of MRI with US in PAS. Findings 3-T MRIdemonstrates high sensitivity and specificity for diagnosing PAS. The combined MRI and US assessment does not further improve diagnostic performance for PAS. Critical relevance statement 3-T MRImay be particularly useful as an adjunct in selected high-risk patients, equivocal ultrasound cases, or cases requiring assessment of myoinvasive disease and multidisciplinary surgical planning.

Insights into ImagingVol. 17(1)
Royal Women's Hospital (AU), The University of Melbourne (AU), Peter MacCallum Cancer Centre (AU), Fiona Stanley Hospital (AU)
Good health and well-being
Maternal and fetal healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon